论文部分内容阅读
Purpose: To evaluate rates of hyperemia in patients treated with latanoprost, bimatoprost, or travoprost and to compare groups in IOP response and costs. Methods: This 3-month, retrospective, multicenter, non-randomized, medical chart review included patients from 10 U.S. sites, who either initiated or changed to latanoprost, bimatoprost, or travoprost for the treatment of primary open-angle glaucoma or ocular hypertension after January 1, 2001. Patients had follow-up data for at least 3 months fol-
Purpose: To evaluate rates of hyperemia in patients treated with latanoprost, bimatoprost, or travoprost and to compare groups in IOP response and costs. Methods: This 3-month, retrospective, multicenter, non-randomized, medical chart review included patients from 10 US sites, who either initiated or changed to latanoprost, bimatoprost, or travoprost for the treatment of primary open-angle glaucoma or ocular hypertension after January 1, 2001. Patients had follow-up data for at least 3 months fol-